Pacira | PCRX - Ordinary Share Capital


Pacira reported $44.9M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Astellas Pharma JPY 1.79B 101.21B Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 584K Sep/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Novo Nordisk DKK 4.44B 0 Sep/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025
Zoetis USD 441.46M 2.48M Sep/2025